Technological
developments

  

A few exemples
     

With a workforce of 350 people and based on a set of modern technology platforms (proteomics, high throughput screening, imaging, animal ...), our institute coordinates research programs of several units under the supervision of CEA, University of Grenoble Alpes ​​and other research organizations (CNRS, Inserm and Inra).

Biosciences and Biotechnology Institute of​ Grenoble - CEA-Grenoble
Head of the Institute: Jérôme Garin
38054 Grenoble cedex 09, France
Phone: 04 38 78 45 01
Fax: 04 38 78 51 55

​Latest publications

Berthet et al.Arabidopsis thaliana plants challenged with uranium reveal new insights into iron and phosphate homeostasis.
New Phytologist, 2018

Wallez et al.CLIQ-BID: A method to quantify bacteria-induced damage to eukaryotic cells by automated live-imaging of bright nuclei.
Scientific Reports, 2018

Raibaut et al. Design of a synthetic luminescent probe from a biomolecule binding domain: Selective detection of AU-rich mRNA sequences.
Chemical Science, 2017

Traboulsi et al. Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo.
Clinical Cancer Research, 2017

Rochefort et al. Soluble VE-cadherin in metastatic breast cancer: An independent prognostic factor for both progression-free survival and overall survival.
British Journal of Cancer, 2017

Burute et al. Polarity reversal by centrosome repositioning primes cell scattering during epithelial-to-mesenchymal transition.
Developmental Cell, 2017

Altamura et al. A synthetic redox biofilm made from metalloprotein-prion domain chimera nanowires.
Nature Chemistry, 2017


Other publications of the institute